Showing 1 - 10 of 16,592
This paper explores one particular vector of entrepreneurship in nanotechnologies: public R&D funding. Drawing mainly from official archival databases and focused interviews I do a comparative study of the EU and US public R&D funding systems. My emphasis is on institutional funding coming from...
Persistent link: https://www.econbiz.de/10014135567
Persistent link: https://www.econbiz.de/10002370414
Persistent link: https://www.econbiz.de/10014285167
This paper tests whether upstream R&D cooperation leads to downstream collusion. We consider an oligopolistic setting where firms enter in research joint ventures (RJVs) to lower production costs or coordinate on collusion in the product market. We show that a sufficient condition for...
Persistent link: https://www.econbiz.de/10008823183
While most economists believe that public scientific research fuels industry innovation and economic growth, systematic … size as a significant driver of drug innovation in the pharmaceutical industry, but they did not find any evidence … supporting science-driven innovation from publicly funded research. This paper uses new data on biomedical research investments …
Persistent link: https://www.econbiz.de/10009374417
contrast, RJVs among non-competitors are efficiency enhancing. -- Research Joint Ventures ; Innovation ; Collusion ; NCRA …
Persistent link: https://www.econbiz.de/10009671907
Persistent link: https://www.econbiz.de/10003716479
increasingly shifts from adaptation to innovation development and knowledge-seeking. In addition, international technological …
Persistent link: https://www.econbiz.de/10011418043
Persistent link: https://www.econbiz.de/10013417754
Persistent link: https://www.econbiz.de/10013420219